183 related articles for article (PubMed ID: 22253891)
1. Involvement of autophagy in cardiac remodeling in transgenic mice with cardiac specific over-expression of human programmed cell death 5.
An L; Zhao X; Wu J; Jia J; Zou Y; Guo X; He L; Zhu H
PLoS One; 2012; 7(1):e30097. PubMed ID: 22253891
[TBL] [Abstract][Full Text] [Related]
2. PDCD5 protects against cardiac remodeling by regulating autophagy and apoptosis.
Zhang S; Li G; Fu X; Qi Y; Li M; Lu G; Hu J; Wang N; Chen Y; Bai Y; Cui M
Biochem Biophys Res Commun; 2015 May; 461(2):321-8. PubMed ID: 25881505
[TBL] [Abstract][Full Text] [Related]
3. Class III PI3K-mediated prolonged activation of autophagy plays a critical role in the transition of cardiac hypertrophy to heart failure.
Yu P; Zhang Y; Li C; Li Y; Jiang S; Zhang X; Ding Z; Tu F; Wu J; Gao X; Li L
J Cell Mol Med; 2015 Jul; 19(7):1710-9. PubMed ID: 25851780
[TBL] [Abstract][Full Text] [Related]
4. Dilated cardiomyopathy resulting from high-level myocardial expression of Cre-recombinase.
Buerger A; Rozhitskaya O; Sherwood MC; Dorfman AL; Bisping E; Abel ED; Pu WT; Izumo S; Jay PY
J Card Fail; 2006 Jun; 12(5):392-8. PubMed ID: 16762803
[TBL] [Abstract][Full Text] [Related]
5. Programmed Cell Death 5 Provides Negative Feedback on Cardiac Hypertrophy Through the Stabilization of Sarco/Endoplasmic Reticulum Ca
Ye J; Zheng Q; Jia S; Qiao X; Cao Y; Xu C; Weng L; Zhao L; Chen Y; Liu J; Wang T; Cheng H; Zheng M
Hypertension; 2018 Oct; 72(4):889-901. PubMed ID: 30354711
[TBL] [Abstract][Full Text] [Related]
6. Deubiquitinating enzyme CYLD mediates pressure overload-induced cardiac maladaptive remodeling and dysfunction via downregulating Nrf2.
Wang H; Lai Y; Mathis BJ; Wang W; Li S; Qu C; Li B; Shao L; Song H; Janicki JS; Sun SC; Wang XL; Tang D; Cui T
J Mol Cell Cardiol; 2015 Jul; 84():143-53. PubMed ID: 25935309
[TBL] [Abstract][Full Text] [Related]
7. Cardiac-specific PID1 overexpression enhances pressure overload-induced cardiac hypertrophy in mice.
Liu Y; Shen Y; Zhu J; Liu M; Li X; Chen Y; Kong X; Song G; Qian L
Cell Physiol Biochem; 2015; 35(5):1975-85. PubMed ID: 25871431
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II-mediated phenotypic cardiomyocyte remodeling leads to age-dependent cardiac dysfunction and failure.
Domenighetti AA; Wang Q; Egger M; Richards SM; Pedrazzini T; Delbridge LM
Hypertension; 2005 Aug; 46(2):426-32. PubMed ID: 15998712
[TBL] [Abstract][Full Text] [Related]
9. Modulation of angiotensin II-mediated cardiac remodeling by the MEF2A target gene Xirp2.
McCalmon SA; Desjardins DM; Ahmad S; Davidoff KS; Snyder CM; Sato K; Ohashi K; Kielbasa OM; Mathew M; Ewen EP; Walsh K; Gavras H; Naya FJ
Circ Res; 2010 Mar; 106(5):952-60. PubMed ID: 20093629
[TBL] [Abstract][Full Text] [Related]
10. Cardiac remodeling is not modulated by overexpression of muscle LIM protein (MLP).
Kuhn C; Frank D; Dierck F; Oehl U; Krebs J; Will R; Lehmann LH; Backs J; Katus HA; Frey N
Basic Res Cardiol; 2012 May; 107(3):262. PubMed ID: 22421737
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of vascular endothelial growth factor-B in mouse heart alters cardiac lipid metabolism and induces myocardial hypertrophy.
Karpanen T; Bry M; Ollila HM; Seppänen-Laakso T; Liimatta E; Leskinen H; Kivelä R; Helkamaa T; Merentie M; Jeltsch M; Paavonen K; Andersson LC; Mervaala E; Hassinen IE; Ylä-Herttuala S; Oresic M; Alitalo K
Circ Res; 2008 Oct; 103(9):1018-26. PubMed ID: 18757827
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin induces dilated cardiomyopathy.
Lee D; Oka T; Hunter B; Robinson A; Papp S; Nakamura K; Srisakuldee W; Nickel BE; Light PE; Dyck JR; Lopaschuk GD; Kardami E; Opas M; Michalak M
PLoS One; 2013; 8(2):e56387. PubMed ID: 23437120
[TBL] [Abstract][Full Text] [Related]
13. Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy.
Pontén A; Li X; Thorén P; Aase K; Sjöblom T; Ostman A; Eriksson U
Am J Pathol; 2003 Aug; 163(2):673-82. PubMed ID: 12875986
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.
Nebigil CG; Jaffré F; Messaddeq N; Hickel P; Monassier L; Launay JM; Maroteaux L
Circulation; 2003 Jul; 107(25):3223-9. PubMed ID: 12810613
[TBL] [Abstract][Full Text] [Related]
15. NF-kappaB activation is required for adaptive cardiac hypertrophy.
Zelarayan L; Renger A; Noack C; Zafiriou MP; Gehrke C; van der Nagel R; Dietz R; de Windt L; Bergmann MW
Cardiovasc Res; 2009 Dec; 84(3):416-24. PubMed ID: 19620128
[TBL] [Abstract][Full Text] [Related]
16. Impaired Protein Quality Control During Left Ventricular Remodeling in Mice With Cardiac Restricted Overexpression of Tumor Necrosis Factor.
Hartupee J; Szalai GD; Wang W; Ma X; Diwan A; Mann DL
Circ Heart Fail; 2017 Dec; 10(12):. PubMed ID: 29203562
[TBL] [Abstract][Full Text] [Related]
17. Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis.
Li Y; Zhou G; La L; Chi X; Cao Y; Liu J; Zhang Z; Chen Y; Wu B
Life Sci; 2013 Jul; 92(24-26):1208-14. PubMed ID: 23688867
[TBL] [Abstract][Full Text] [Related]
18. Neuron-derived orphan receptor-1 modulates cardiac gene expression and exacerbates angiotensin II-induced cardiac hypertrophy.
Cañes L; Martí-Pàmies I; Ballester-Servera C; Herraiz-Martínez A; Alonso J; Galán M; Nistal JF; Muniesa P; Osada J; Hove-Madsen L; Rodríguez C; Martínez-González J
Clin Sci (Lond); 2020 Feb; 134(3):359-377. PubMed ID: 31985010
[TBL] [Abstract][Full Text] [Related]
19. FoxO3 induces reversible cardiac atrophy and autophagy in a transgenic mouse model.
Schips TG; Wietelmann A; Höhn K; Schimanski S; Walther P; Braun T; Wirth T; Maier HJ
Cardiovasc Res; 2011 Sep; 91(4):587-97. PubMed ID: 21628326
[TBL] [Abstract][Full Text] [Related]
20. Autophagy during cardiac remodeling.
Nishida K; Otsu K
J Mol Cell Cardiol; 2016 Jun; 95():11-8. PubMed ID: 26678624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
